Practice with mock tests, learn from structured notes, and get your questions answered by a global forensic community, all in one place.
ELISA and related immunoassay formats that quantify or detect human haemoglobin with exceptional sensitivity, and how their sensitivity, cross-reactivity profiles, and reporting requirements compare with classical precipitin and lateral-flow methods.
Last updated:
Every immunoassay in forensic serology operates on the same core concept: an antibody binds its antigen, and the binding event is made visible. Lateral-flow cards do this with colloidal gold on a nitrocellulose strip. The Enzyme-Linked Immunosorbent Assay (ELISA) does it on a microplate well with an enzyme that turns a substrate from colourless to coloured, and the colour intensity is measured rather than simply read as present or absent. That difference, quantitation, is what separates ELISA from lateral-flow in many forensic applications.
ELISA has been a workhorse of clinical and research immunology since Peter Engvall and Anton Schuurs published the method in 1971. Forensic serology adopted it because the same sandwich format that detects blood-borne viruses at nanogram-per-millilitre concentrations can be tuned to detect human haemoglobin with extraordinary sensitivity, far below the visual threshold and well beyond what classical crystal tests can reach. In principle, a bloodstain invisible to the eye can still yield enough haemoglobin for a quantitative ELISA result.
This topic explains the ELISA format in enough technical detail to understand what the numbers mean, covers the cross-reactivity profile for anti-human haemoglobin ELISA kits, and places the method in the forensic workflow alongside lateral-flow immunochromatography and the classical precipitin tests. The goal is to understand when each tool is the right one rather than to pick a favourite.
Two antibodies, one antigen, one microplate well, and a colour that tells you how much.
In the sandwich ELISA for human haemoglobin, the capture antibody is adsorbed onto the walls of a polystyrene microplate well. The sample extract is added to the well; any human haemoglobin in the extract binds to the capture antibody. The well is washed to remove unbound material. Then the detection antibody, conjugated to an enzyme (usually horseradish peroxidase), is added. It binds to the captured haemoglobin from a different epitope. After another wash to remove unbound detection antibody, the enzyme substrate is added. The enzyme catalyses a colour reaction, and the microplate reader measures the optical density at the appropriate wavelength.
The optical density of the sample well is compared to a standard curve constructed from wells containing known haemoglobin concentrations (typically spanning from 0 to several hundred nanograms per millilitre). Interpolating the sample OD against the curve gives a concentration in nanograms per millilitre of the extract, which can then be converted to an estimate of blood volume using the known haemoglobin content of whole blood (approximately 14-16 grams per 100 millilitres).
The numbers are striking. A stain too small to see can still be quantified.
The limit of detection for a well-optimised anti-human haemoglobin sandwich ELISA is typically in the range of 0.1 to 1 nanogram of haemoglobin per millilitre of extract. Given that a microlitre of whole blood contains approximately 140 micrograms of haemoglobin, this means a positive ELISA result can in principle be obtained from a bloodstain equivalent to a fraction of a nanolitre of whole blood, an amount invisible to the eye and barely detectable by a swab.
| Method | Approximate sensitivity | Output type |
|---|---|---|
| Teichmann crystal test | Stains visible to eye; approximate lower limit ~1:1,000 whole blood | Qualitative (crystals visible or not) |
| Takayama crystal test | Slightly better than Teichmann on aged stains | Qualitative |
| ABAcard HemaTrace / RSID-Blood | ~1:100,000 whole blood dilution | Qualitative (two-band positive/negative) |
| ELISA (sandwich format) | Sub-nanogram/mL; ~1:1,000,000+ whole blood | Quantitative (OD against standard curve) |
This sensitivity advantage is not always practically relevant. In most casework, the stain is large enough that a lateral-flow test gives a clear positive, and quantitation adds little to the investigation. ELISA sensitivity matters most at the edges: very small or heavily diluted stains, samples where the lateral-flow band is absent but the investigative context suggests blood is likely, and cases where blood volume estimation is required.
No antibody is perfectly exclusive, and the validation data tells you exactly where the edges are.
The cross-reactivity profile of an anti-human haemoglobin ELISA depends on the specific monoclonal or polyclonal antibodies used. Antibody manufacturers and forensic validation studies typically test extracts from a range of common and uncommon animal species and report the response as a percentage of the response to pure human haemoglobin at the same protein concentration. A cross-reactivity below 5% is generally considered acceptable for a test claiming human specificity.
The pattern is consistent with what is seen in lateral-flow assays. Great apes (gorilla, chimpanzee, orangutan) cross-react significantly because their haemoglobin amino acid sequences are closely homologous to human haemoglobin. Ferret haemoglobin shows partial cross-reactivity in most validation studies. Dog, cat, horse, pig, cow, sheep, deer, rat, mouse, and rabbit do not show significant cross-reactivity with well-validated anti-human Hb antibodies.
A number is more informative than a band, when the question demands a number.
The quantitative output of ELISA is its most distinctive contribution relative to lateral-flow methods. A haemoglobin concentration in the stain extract can be used to estimate how much blood was deposited, which can be relevant to case interpretation. A stain containing the equivalent of several millilitres of blood is harder to explain by accidental secondary contact than a stain consistent with a microlitre or less.
Quantitation also matters when assessing whether a negative lateral-flow result is truly negative or simply below the assay's threshold. If ELISA detects haemoglobin at a concentration below the lateral-flow LOD, the analyst can report a trace detection that the lateral-flow card missed. This is useful in cases where the biological interpretation of a very small stain is contested.
Each method answers a slightly different question. The forensic workflow fits them together.
A forensic serologist choosing between methods is really choosing between questions. Do I need to confirm blood? Do I need to know it is human? Do I need a quantity? Do I need to document it in a format that survives cross-examination? Each method answers one or more of these questions better than the others.
| Method | Confirms blood | Identifies human | Quantitative | Identifies species |
|---|---|---|---|---|
| Teichmann / Takayama crystal tests | Yes | No | No | No |
| ABAcard HemaTrace / RSID-Blood | Yes | Yes (with cross-reactivity caveat) | No | No |
| Ring precipitin / Ouchterlony | No (serum proteins, not specifically Hb) | Yes | No | Yes (with correct antiserum) |
| Anti-human Hb ELISA | Yes (via Hb detection) | Yes (with cross-reactivity caveat) | Yes | No |
In most contemporary forensic workflows, the lateral-flow test (HemaTrace or RSID-Blood) is the front-line confirmatory test for human blood because it is fast, sensitive, and simple. ELISA steps in when quantitation is needed or sensitivity must be pushed lower. Classical precipitin tests are most used today for species identification in non-human blood contexts. Crystal tests remain valid second confirmations, particularly when the result will be challenged on the basis of antibody kit quality.
A number without its uncertainty, method, and cross-reactivity disclosure is incomplete.
Reporting an ELISA result in a forensic context requires more documentation than a lateral-flow read because the output is quantitative and can be misinterpreted without context. The report should specify: the assay kit and antibody lot number used, the extraction method and solvent volume, the standard curve data (at least the R-squared value and the range), the OD of the sample, the calculated haemoglobin concentration, the extraction efficiency assumption used for any blood volume estimate, and the cross-reactivity statement for any relevant species.
If a blood volume estimate is reported, the uncertainty range must be stated. A haemoglobin concentration of 0.5 micrograms per millilitre in an extract prepared from a fabric swab, using an assumed 50% extraction efficiency, does not translate to a precise 1 microlitre of blood. It translates to a range, and the forensic report says so. Courts have repeatedly accepted ELISA results from accredited laboratories where the uncertainty was properly disclosed; they have also excluded or challenged results where the uncertainty was hidden or the cross-reactivity matrix was not provided.
In a sandwich ELISA for human haemoglobin, what produces the colour signal?
Test yourself on Forensic Serology with free, timed mocks.
Practice Forensic Serology questionsSpotted an error in this page? Report a correction or read our editorial standards.